This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Humanitas Mirasole S.p.a.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Giuseppe Celesti: Innovator in Cancer Diagnosis
Introduction
Giuseppe Celesti is a notable inventor based in Rozzano, Italy. He has made significant contributions to the field of cancer diagnosis, particularly focusing on colorectal and pancreatic cancers. His innovative approach combines molecular biology with clinical diagnostics, aiming to improve patient outcomes through early detection.
Latest Patents
Giuseppe Celesti holds a patent for a method that determines if a subject is affected by colorectal or pancreatic cancer. This method involves measuring the presence of a panel of mRNAs encoding transcription factors and genes involved in epithelial to mesenchymal transition in blood samples. The specific mRNA levels of genes such as TWIST1, SLUG, ZEB2, ZEB1, and CDH1 are indicative of cancer diagnosis and progression. This invention also includes the use of kits designed to facilitate the method.
Career Highlights
Giuseppe Celesti is associated with Humanitas Mirasole S.p.a., where he applies his expertise in cancer research and diagnostics. His work has been instrumental in advancing methodologies that enhance the accuracy of cancer detection and staging.
Collaborations
Giuseppe collaborates with Luigi Laghi, contributing to the development of innovative diagnostic techniques. Their partnership exemplifies the importance of teamwork in scientific research and innovation.
Conclusion
Giuseppe Celesti's contributions to cancer diagnosis through his patented methods highlight the critical role of innovation in healthcare. His work not only advances scientific knowledge but also has the potential to significantly impact patient care.